However, our immunohistochemical results showed that the percentage of patients with PSMA-positive cells has no significant correlation with the size of the primary tumor mass or lymph node metastasis in NSCLC or SCLC, and the underlying reason for this needs to be further studied in the future. This evidence concerns the gene FOLH1 and small cell lung carcinoma.